Entero Healthcare Solutions Complete Financial Statements
In FY2026, Entero Healthcare Solutions (ENTERO) reported revenue ₹1,914 Cr, net profit ₹45 Cr and EPS ₹6.44, with a net profit margin of 2.4% and ROE of 2.7%. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse ENTERO shareholding pattern to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
ENTERO Revenue, Net Profit & EBITDA — Year-on-Year Growth
ENTERO YoY (Mar 2025 vs Mar 2026) — revenue +42.2%, net profit +45.2%, EBITDA +60.7%, expenses +41.4%. For live price, earnings ratios and company overview, see Entero Healthcare Solutions share price today.
ENTERO Income Statement — Revenue, EBITDA & Net Profit
Entero Healthcare Solutions revenue ₹1,914 Cr, EBITDA ₹90 Cr, net profit ₹45 Cr, EPS ₹6.44 (2026) — net profit margin 2.4%. Examine ENTERO quarterly results for recent quarterly revenue, profit and EPS trends.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,914 | 1,576 | 1,346 | 1,410 | 1,711 | 1,312 | 1,043 | 1,111 | 1,367 | 998 | 888 | 901 | 994 | 832 |
| Expenses | 1,824 | 1,509 | 1,290 | 1,354 | 1,647 | 1,258 | 1,005 | 1,067 | 1,309 | 968 | 867 | 873 | 964 | 810 |
| EBITDA | 90 | 67 | 56 | 56 | 64 | 54 | 38 | 44 | 58 | 31 | 21 | 27 | 30 | 21 |
| Operating Profit Margin % | 5.00% | 4.00% | 4.00% | 4.00% | 3.00% | 3.00% | 3.00% | 3.00% | 4.00% | 3.00% | 2.00% | 3.00% | 3.00% | 2.00% |
| Depreciation | 15 | 10 | 9 | 9 | 10 | 8 | 7 | 7 | 8 | 6 | 7 | 6 | 6 | 5 |
| Interest | 17 | 12 | 11 | 11 | 14 | 12 | 17 | 10 | 10 | 18 | 13 | 14 | 16 | 13 |
| Profit Before Tax | 58 | 45 | 37 | 36 | 40 | 35 | 14 | 27 | 39 | 7 | 1 | 7 | 8 | 3 |
| Tax | 13 | 8 | 6 | 6 | 7 | 9 | -8 | 7 | 10 | 2 | 5 | 0 | 1 | -1 |
| Net Profit | 45 | 37 | 31 | 30 | 34 | 26 | 21 | 21 | 30 | 5 | -4 | 6 | 7 | 4 |
| Earnings Per Share (₹) | 6.44 | 7.26 | 5.91 | 6.39 | 6.35 | 5.43 | 5.73 | 4.62 | 5.85 | 3.24 | 1.49 | 15.18 | 4.21 | 8.67 |
ENTERO Balance Sheet — Assets, Liabilities & Shareholders' Equity
ENTERO total assets ₹3,600 Cr, total equity ₹1,689 Cr, total liabilities ₹ Cr (2026) — ROE 2.7%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Total Assets | 3,600 | 2,703 | 2,345 | 1,309 | 1,126 | 836 | 749 |
| Current Assets | 2,508 | 2,076 | 2,011 | 1,023 | 851 | 636 | 552 |
| Fixed Assets | 211 | 559 | 289 | 268 | 262 | 189 | 186 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Investments | 842 | 58 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 2,085 | 2,056 | 1,041 | 863 | 645 | 561 |
| LIABILITIES | |||||||
| Total Liabilities | |||||||
| Current Liabilities | 260 | 87 | 102 | 87 | 101 | 58 | 56 |
| Non-Current Liabilities | |||||||
| SHAREHOLDERS' EQUITY | |||||||
| Total Equity | 1,689 | 1,770 | 1,641 | 598 | 563 | 487 | 424 |
| Share Capital | 44 | 44 | 44 | 4 | 4 | 517 | 439 |
| Reserves & Surplus | 1,645 | 1,676 | 1,593 | -73 | -62 | -32 | -16 |
ENTERO Cash Flow Statement — Operating, Investing & Financing
Entero Healthcare Solutions operating cash flow ₹-77 Cr, investing ₹232 Cr, financing ₹-74 Cr, net cash flow ₹82 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | -77 | -37 | -45 | -35 | -69 | -37 |
| Investing Activities | 232 | -704 | -49 | -162 | -31 | -203 |
| Financing Activities | -74 | 863 | 73 | 211 | 89 | 217 |
| Net Cash Flow | 82 | 122 | -21 | 14 | -11 | -23 |